Stocks & Investing
Fri, August 9, 2024
[ Fri, Aug 09th 2024
] - WOPRAI
Mon, June 3, 2024
[ Mon, Jun 03rd 2024
] - WOPRAI
Mon, April 8, 2024
[ Mon, Apr 08th 2024
] - WOPRAI
Thu, April 4, 2024
[ Thu, Apr 04th 2024
] - WOPRAI
Fri, December 8, 2023
[ Fri, Dec 08th 2023
] - WOPRAI
[ Fri, Dec 08th 2023
] - WOPRAI
Wed, November 29, 2023
[ Wed, Nov 29th 2023
] - WOPRAI
Thu, October 12, 2023
[ Thu, Oct 12th 2023
] - WOPRAI
Tue, September 5, 2023
[ Tue, Sep 05th 2023
] - WOPRAI
Wed, August 9, 2023
[ Wed, Aug 09th 2023
] - WOPRAI
Tue, July 18, 2023
[ Tue, Jul 18th 2023
] - WOPRAI
Thu, May 11, 2023
[ Thu, May 11th 2023
] - WOPRAI
Tue, April 25, 2023
[ Tue, Apr 25th 2023
] - WOPRAI
Tue, December 13, 2022
[ Tue, Dec 13th 2022
] - WOPRAI
[ Tue, Dec 13th 2022
] - WOPRAI
Samantha Semenkow Maintained (ALLO) at Strong Buy with Increased Target to $8 on, Aug 9th, 2024
Samantha Semenkow of Citigroup, Maintained "Allogene Therapeutics, Inc." (ALLO) at Strong Buy with Increased Target from $7 to $8 on, Aug 9th, 2024.
Samantha has made no other calls on ALLO in the last 4 months.
There are 6 other peers that have a rating on ALLO. Out of the 6 peers that are also analyzing ALLO, 1 agrees with Samantha's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Benjamin Burnett of "Stifel" Maintained at Hold with Increased Target to $4.6 on, Tuesday, May 14th, 2024
These are the ratings of the 5 analyists that currently disagree with Samantha
- John Newman of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $14 on, Thursday, August 8th, 2024
- Matthew Biegler of "Oppenheimer" Initiated at Buy with Decreased Target to $11 on, Thursday, August 8th, 2024
- Biren Amin of "Piper Sandler" Initiated at Buy and Held Target at $11 on, Friday, May 31st, 2024
- Mark Breidenbach of "Oppenheimer" Maintained at Buy with Decreased Target to $13 on, Tuesday, May 21st, 2024
- Robert Burns of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $9 on, Thursday, May 16th, 2024
